remedies
The Ripple-SEC Saga: Why the Latest Remedies Filing Remains a Bellwether for Crypto Regulation
The legal battle between Ripple Labs and the U.S. Securities and Exchange Commission (SEC) has long transcended the status of a simple corporate dispute. For years, it has served as the primary theater for the existential struggle between decentralized finance and traditional regulatory frameworks. While a recent supplemental filing in the remedies phase of the […]
The SEC v. Ripple Remedies Phase: Mapping the Final Steps and Market Implications
The multi-year legal battle between the U.S. Securities and Exchange Commission (SEC) and Ripple Labs Inc. has entered its final, highly technical stretch. While the initial, explosive phase of the litigation—marked by dramatic liability rulings and regulatory standoffs—has concluded, the industry’s focus has shifted to the "remedies phase" and the subsequent appellate timeline. For XRP […]
